YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
The Fidelity MSCI Health Care Index ETF (NYSEMKT:FHLC) provides broad, low-cost access to the entire healthcare sector, whereas the Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) targets a narrower slice of biotech with higher recent retur…
The Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) offers lower costs and broader market diversification, while the VanEck Biotech ETF (NASDAQ:BBH) provides a more concentrated investment in 25 leading biotechnology companies. Both funds t…
[Health Care Medical Stock Market Industry Sector Wall Street Buildings 3d Illustration] iQoncept/iStock via Getty Images Short interest data from late July 2026 highlights deeply divided investor sentiment across the healthcare sector. St…
Key Points The Health Care Select Sector SPDR Fund (XLV) carries a lower expense ratio and a higher dividend yield than the Invesco Nasdaq Biotechnology ETF (IBBQ). IBBQ has significantly outperformed on a one-year basis, but has also expe…
The State Street Health Care Select Sector SPDR ETF (NYSEMKT:XLV) provides broad exposure to the S&P 500 healthcare sector, whereas the Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) offers a targeted focus on biotechnology and pharmaceuti…
Key Points The Vanguard Health Care ETF offers a lower expense ratio and higher dividend yield compared to the Invesco Nasdaq Biotechnology ETF. The Invesco Nasdaq Biotechnology ETF has outperformed on 1-year total returns but carries a si…
The Vanguard Health Care ETF (NYSEMKT:VHT) offers broad sector exposure and lower costs, while the Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) provides a concentrated, higher-volatility play on biotech innovation and pharmaceutical rese…
Investors choosing between iShares Global Healthcare ETF (NYSEMKT:IXJ) and Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) may weigh broad global diversification and higher dividend yields against lower costs and specialized high-growth pot…
The iShares Global Healthcare ETF (NYSEMKT:IXJ) provides broad, established exposure to global healthcare giants, while the Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) offers a lower-cost concentrated bet on biotechnology. Both funds gi…
[Health Care Medical Stock Market Industry Sector Wall Street Buildings 3d Illustration] iQoncept/iStock via Getty Images The Health Care Select Sector SPDR® Fund ETF (XLV [https://seekingalpha.com/symbol/XLV]), which tracks the health car…
The State Street Health Care Select Sector SPDR ETF (NYSEMKT:XLV) provides broad-based exposure to the healthcare sector at lower costs and lower volatility, while the Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) offers focused exposure…
Key Points State Street Health Care Select Sector SPDR ETF offers a lower expense ratio and a higher dividend yield than Invesco Nasdaq Biotechnology ETF Invesco Nasdaq Biotechnology ETF provides concentrated exposure to the biotech indust…
The Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) and State Street SPDR S&P Pharmaceuticals ETF (NYSEMKT:XPH) both target healthcare innovation but differ in their diversification levels and cost structures. These two funds provide distin…
Key Points Invesco Nasdaq Biotechnology ETF features a significantly lower expense ratio and higher trailing-12-month dividend yield than State Street SPDR S&P Pharmaceuticals ETF State Street SPDR S&P Pharmaceuticals ETF offers a more est…
Investors choosing between Invesco Nasdaq Biotechnology ETF(NASDAQ:IBBQ) and State Street SPDR S&P Pharmaceuticals ETF(NYSEMKT:XPH) could weigh the lower costs and broader diversification of IBBQ against the established size and pharmaceut…
Short interest in small-cap healthcare surged toward the end of January, centering heavily on the biotechnology sector. Data as of January 30 shows that KalVista (KALV [https://seekingalpha.com/symbol/KALV]) and Intellia (NTLA [https://see…
21 out of 60 S&P 500 health care companies reported quarterly results this week, of which 20 delivered an earnings beat, and one came in-line with estimates. 16 of the reporting companies exceeded revenue consensus, while five trailed expe…
[Health Care Medical Stock Market Industry Sector Wall Street Buildings 3d Illustration] iQoncept/iStock via Getty Images The Health Care Select Sector SPDR® Fund ETF (NYSEARCA:XLV [https://seekingalpha.com/symbol/XLV]), which tracks the h…
[Health Care Medical Stock Market Industry Sector Wall Street Buildings 3d Illustration] iQoncept/iStock via Getty Images The S&P 500 Healthcare sector (XLV) saw a slight increase in average short interest in September, rising to 1.91% fro…
[Sector index data, health care, industrials, insurance.] Torsten Asmus/iStock via Getty Images The Health Care Select Sector SPDR® Fund ETF (NYSEARCA:XLV [https://seekingalpha.com/symbol/XLV]), which tracks the health care sector, and hol…
* Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ [https://seekingalpha.com/symbol/IBBQ]) - $0.0958 [https://www.invesco.com/us/financial-products/etfs/product-detail?audienceType=Advisor&productId=ETF-IBBQ]. * 30-Day SEC Yield of 0.48% as o…
[Stock Market Health Care Index. Trading screen with a sector index for Health Care, quotes, charts and changes.] Torsten Asmus The average short interest in the S&P 500 Healthcare sector (NYSEARCA:XLV [https://seekingalpha.com/symbol/XLV]…
[Health Care Medical Stock Market Industry Sector Wall Street Buildings 3d Illustration] iQoncept/iStock via Getty Images The average short interest in the S&P 500 Health Care Index Sector (NYSEARCA:XLV [https://seekingalpha.com/symbol/XLV…
The average short interest for the S&P 500 Health Care Index Sector (NYSEARCA:XLV [https://seekingalpha.com/symbol/XLV]) experienced an increase in June, moving from 1.90% in May to 1.96%, indicating a collective rise in negative bets agai…
[Health Care Medical Stock Market Industry Sector Wall Street Buildings 3d Illustration] iQoncept/iStock via Getty Images The Health Care Select Sector SPDR® Fund ETF (NYSEARCA:XLV [https://seekingalpha.com/symbol/XLV]), which tracks the h…
* Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ [https://seekingalpha.com/symbol/IBBQ]) - $0.02870. * Payable Jun 27; for shareholders of record Jun 23; ex-div Jun 23. MORE ON INVESCO NASDAQ BIOTECHNOLOGY ETF * Short bets on S&P 500 Health…
[Health Care Medical Stock Market Industry Sector Wall Street Buildings 3d Illustration] iQoncept/iStock via Getty Images The negative sentiment towards the S&P 500 Health Care Index Sector (NYSEARCA:XLV [https://seekingalpha.com/symbol/XL…
In this article, we discuss 11 best biotech ETFs to buy. If you want to skip our discussion on the biotech industry, head over to 5 Best Biotech ETFs To Buy. The new era in biotech is defined by the convergence of biology, data, and artifi…
Investment company Apexium Financial, LP (Current Portfolio) buys Fidelity MSCI Health Care Index ETF, Fidelity MSCI Information Technology Index ETF, Invesco Nasdaq Biotechnology ETF, Schwab US Dividend Equity ETF, iShares U.S. Technology…
Eli Lilly CEO David Ricks joins 'Influencers with Andy Serwer' to discuss progress in the fight against COVID-19. Video Transcript ANDY SERWER: He said recently that the Biden administration's support for an intellectual property waiver fo…
In this episode of Influencers, Eli Lilly Chairman & CEO David Ricks joins Andy to discuss the latest in the pharmaceutical industry, new progress in the fight against COVID-19, and potential groundbreaking advancements for the treatment o…
Eli Lilly CEO David Ricks joins 'Influencers with Andy Serwer' to discuss progress in the fight against COVID-19. Video Transcript ANDY SERWER: He said recently that the Biden administration's support for an intellectual property waiver fo…
In this episode of Influencers, Eli Lilly Chairman & CEO David Ricks joins Andy to discuss the latest in the pharmaceutical industry, new progress in the fight against COVID-19, and potential groundbreaking advancements for the treatment o…
Eli Lilly CEO David Ricks joins 'Influencers with Andy Serwer' to discuss the FDA's approval of Biogen's new Alzheimer’s drug. Video Transcript ANDY SERWER: In the news this week is the FDA'S approval of Biogen's Alzheimer's drug. What's y…
Eli Lilly CEO David Ricks joins 'Influencers with Andy Serwer' to discuss the FDA's approval of Biogen's new Alzheimer’s drug. Video Transcript ANDY SERWER: In the news this week is the FDA'S approval of Biogen's Alzheimer's drug. What's y…
Innovative ETFs will track well-recognized Nasdaq Indexes with nearly 30 years of live track record ATLANTA, June 11, 2021 /PRNewswire/ -- Invesco Ltd. (NYSE: IVZ), a leading global asset manager, announced today the launch of two new exch…